POLICY FOR PATIENT GROUP DIRECTIONS (PGD) - NHS

More documents

Recommendations

Info

2. Background2.1. In 1997, the DH commissioned a Review of the Prescribing, Supply andAdministration of Medicines. The Review Group, chaired by Dr June Crown CBEsubmitted its final report to the Secretary of State for Health in March 1999. Thefirst report of the Review Group concerning the supply and administration ofmedicines by Group Protocol was published in April 1998. Recommendations fromthis report were circulated by the NHS Executive in the Health Services Circular(HSC 1998/051): Report on the Supply of Medicines under Group Protocols.2.2. On 9 th August 2000 new legislation on the supply and administration of medicinescame into effect. The legislation authorises the supply and/or administration ofmedicines, where the medicine is supplied for the purpose of being administered oris administered, in accordance with a Patient Group Direction (HSC/2000/026).2.3. Patient Group Directions (PGDs), in existence since August 2000, constitute a legalframework which allows certain health care professionals to supply and administermedicines to groups of patients that fit the criteria laid out in the PGD without theneed for a prescription or an instruction from the prescriber2.4. This policy has been developed to ensure that NHS Leicester City complies withthe legal requirements of HSC 2000/026, 9 August 2000, Patient Group Directions(England Only).2.5. A Patient Group Direction (PGD) is a specific written instruction for the supply oradministration of a named medicine in an identified clinical situation. The PGDshould be locally developed by doctors, pharmacists and other appropriateprofessionals, and approved by the employer, advised by the relevant professionaladvisory committees.2.6. The majority of clinical care should be provided on an individual, patient specificbasis. The supply and administration of medicines under patient group directionsshould be reserved for those limited situations where this offers an advantage forpatient care (without compromising patient safety), and where it is consistent withappropriate professional relationships and accountability. An example of this is theprovision of immunisations and vaccinations3. Policy statementThis policy aims to deliver the following:3.1 Define a consistent, safe and effective process to develop, implement and reviewPatient Group Directions within the law.3.2 Define a method of joint working to reduce duplication of work.3.3 Define health professional responsibility with respect to their role to develop andimplement Patient Group Directions.3.4 Define the responsibility of health professionals with respect to their role to supplyand administer under Patient Group Directions.Policy for the development of Patient Group Directions (PGD)Page 4 of 23
4. Scope of the PolicyThis policy applies to:4.1 All qualified health professionals and directorates within NHS Leicester City(NHSLC) and/or Leicester City Community Health Services (LCCHS) who wish todevelop Patient Group Directions for use in their own area of work.4.2 All qualified health professionals who wish to supply or administer medicines undera Patient Group Direction in NHSLC and/ or LCCHS.4.3 Managers, Medicines Management Committee and Clinical Governance Leads whoare responsible for approval of the use of a Patient Group Direction in NHSLC and/or LCCHS.4.4 All qualified health professionals who are entitled to act under Patient GroupDirections.4.5 Health professionals can only act within the Patient Group Direction as namedindividuals and must act within their appropriate Code of Professional Conduct.5. Statutory Requirements5.1. HSC 2000/026 clarifies the legal position with respect to the use of “group protocols”recommended in the Report on the Supply and Administration of Medicines underGroup Protocols.5.2. The legal term for these protocols is Patient Group Directions (PGD).5.3. A Patient Group Direction is a written instruction to supply and or administer amedicine to groups of patients who may not be individually identified beforepresentation for treatment.5.4. A Patient Group Direction must be signed by a Senior Doctor, a senior pharmacistand a senior nurse and be authorised for use by the PCT5.5. Qualified health professionals who are entitled to act under Patient Group Directionsinclude nurses, midwives, health visitors, optometrists, pharmacists, chiropodists,radiographers, orthoptists, physiotherapists and ambulance paramedics. They canonly do so as named individuals.5.5.1. Pharmacists5.5.2. Registered nurses5.5.3. Registered health visitors5.5.4. Registered midwives5.5.5. Registered dieticians5.5.6. Registered physiotherapists5.5.7. Registered occupational therapists5.5.8. Registered speech & language therapists5.5.9. Registered optometristsPolicy for the development of Patient Group Directions (PGD)Page 5 of 23
Page 1 and 2: POLICY DOCUMENTPOLICY FOR PATIENT G
Page 6 and 7: 5.5.10. Registered orthoptists5.5.1
Page 8 and 9: 6.2. Development Process steps6.2.1
Page 10 and 11: 6.4.2. Is the most appropriate meth
Page 12 and 13: 8.14 The content of competency asse
Page 14 and 15: Appendix 12.1TEMPLATEPATIENT GROUP
Page 16 and 17: PATIENTGROUPDIRECTION(PGD)(PGD)[NAM
Page 18 and 19: PATIENTGROUPDIRECTION(PGD)(PGD)[NAM
Page 20 and 21: INDIVIDUAL AUTHORISATIONPGDs DO NOT
Page 22 and 23: Knowledge/Competency beingassessedU

POLICY FOR PATIENT GROUP DIRECTIONS (PGD) - NHS

Create successful ePaper yourself

Delete template?

Save as template?